Plasma Exosomal CXCL7 is a Potential Biomarker for Lung Adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical laboratory"
DOI: 10.7754/clin.lab.2022.220128
Abstract: BACKGROUND Lung cancer is a leading cause of cancer-related death, with lung adenocarcinoma (LUAD) representing the most common subtype. Recently, exosome-based biomarkers have provided new diagnostic approaches for malignancies. METHODS The differential expression profile of… read more here.
Keywords: exosomal cxcl7; plasma exosomal; lung adenocarcinoma;